The combination of the reduced concentration of Aβ42 and high concentrations of p-tau and t-tau comprises the so called “AD signature” in CSF, which has been shown to be highly predictive of progression to AD dementia in mild cognitive impairment (MCI) patients [41,54,57,58,59]. The gene discussed is MAPT; the disease is Cognitive impairment.